Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation

European Journal of Surgical Oncology

Volumn 41, Issue 7, 2015, Pages 920-926

  Klevebro, F ^a   Johnsen, G ^b   Johnson, E ^c   Viste, A ^d,h   Myrnas T ^e   Szabo, E ^f   Jacobsen, A B ^g   Friesland, S ^a   Tsai, J A ^a   Persson, S ^a   Lindblad, M ^a   Lundell, L ^a   Nilsson, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY OF BERGEN   (Norway)

Author keywords

Neoadjuvant treatment; Oesophageal cancer; Oesophagectomy complications

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLAVIEN DINDO COMPLICATION SEVERITY SCORE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROOESOPHAGEAL JUNCTION CARCINOMA; HEARING IMPAIRMENT; HUMAN; INCIDENCE; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NORWAY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; SWEDEN; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COMPARATIVE STUDY; ESOPHAGEAL NEOPLASMS; FOLLOW UP; LOWER ESOPHAGUS SPHINCTER; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MORBIDITY; NEOADJUVANT THERAPY; NEOPLASM STAGING; NORWAY; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME;

EID: 84930763270     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.03.226     Document Type: Article

References (24)

1. P.C. Enzinger, and R.J. Mayer Esophageal cancer N Engl J Med 349 23 2003 Dec 4 2241 2252 PubMed PMID: 14657432
2. C. Schieman, D.A. Wigle, C. Deschamps, et al. Patterns of operative mortality following esophagectomy Dis Esophagus 25 7 2012 Sep-Oct 645 651 PubMed PMID: 22243561
3. B.L. Liedman, K. Bennegard, L.C. Olbe, and L.R. Lundell Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas Eur J Surg 161 3 1995 Mar 173 180 PubMed PMID: 7599295
4. K.M. Sjoquist, B.H. Burmeister, B.M. Smithers, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol 12 7 2011 Jul 681 692 PubMed PMID: 21684205
5. P. van Hagen, M.C. Hulshof, J.J. van Lanschot, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 22 2012 May 31 2074 2084 PubMed PMID: 22646630
6. W.H. Allum, S.P. Stenning, J. Bancewicz, P.I. Clark, and R.E. Langley Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol 27 30 2009 Oct 20 5062 5067 PubMed PMID: 19770374
7. B.H. Burmeister, J.M. Thomas, E.A. Burmeister, et al. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomized phase II trial Eur J Cancer 47 3 2011 Feb 354 360 PubMed PMID: 21084184
8. M. Stahl, M.K. Walz, M. Stuschke, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 6 2009 Feb 20 851 856 PubMed PMID: 19139439
9. K. Kumagai, I. Rouvelas, J.A. Tsai, et al. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers Br J Surg 101 4 2014 Mar 321 338 PubMed PMID: 24493117
10. P.A. Clavien, J.R. Sanabria, and S.M. Strasberg Proposed classification of complications of surgery with examples of utility in cholecystectomy Surgery 111 5 1992 May 518 526 PubMed PMID: 1598671
11. D. Dindo, N. Demartines, P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2 2004 Aug 205 213 PubMed PMID: 15273542. Pubmed Central PMCID: 1360123
12. K. Slankamenac, R. Graf, J. Barkun, M.A. Puhan, and P.A. Clavien The comprehensive complication index: a novel continuous scale to measure surgical morbidity Ann Surg 258 1 2013 Jul 1 7 PubMed PMID: 23728278. Epub 2013/06/04. eng
13. S. Mukherjee, D. Aston, M. Minett, A.E. Brewster, and T.D. Crosby The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers Clin Oncol 15 3 2003 May 115 120 PubMed PMID: 12801047
14. P. Tripp, H.K. Malhotra, M. Javle, et al. Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes Dis Esophagus 18 6 2005 400 405 PubMed PMID: 16336612
15. J.L. Januzzi Jr., A.S. Maisel, M. Silver, Y. Xue, and C. DeFilippi Natriuretic peptide testing for predicting adverse events following heart failure hospitalization Congest Heart Fail 18 Suppl 1 2012 Sep-Oct S9 S13 PubMed PMID: 22891803
16. G. Karthikeyan, R.A. Moncur, O. Levine, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies J Am Coll Cardiol 54 17 2009 Oct 20 1599 1606 PubMed PMID: 19833258
17. E. Senkus, and J. Jassem Cardiovascular effects of systemic cancer treatment Cancer Treat Rev 37 4 2011 Jun 300 311 PubMed PMID: 21126826
18. S.L. Kwa, J.V. Lebesque, J.C. Theuws, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients Int J Radiat Oncol Biol Phys 42 1 1998 Aug 1 1 9 PubMed PMID: 9747813
19. G.W. Morgan, and S.N. Breit Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury Int J Radiat Oncol Biol Phys 31 2 1995 Jan 15 361 369 PubMed PMID: 7836090
20. J. Wang, C. Wei, S.L. Tucker, et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer Int J Radiat Oncol Biol Phys 86 5 2013 Aug 1 885 891 PubMed PMID: 23845841. Pubmed Central PMCID: PMC3786201. Epub 2013/07/13. eng
21. R. Gopal, S.L. Tucker, R. Komaki, et al. The relationship between local dose and loss of function for irradiated lung Int J Radiat Oncol Biol Phys 56 1 2003 May 1 106 113 PubMed PMID: 12694828
22. S. Wang, Z. Liao, X. Wei, et al. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy J Thorac Oncol 3 3 2008 Mar 277 282 PubMed PMID: 18317071
23. B. Liedman, E. Johnsson, C. Merke, M. Ruth, and L. Lundell Preoperative adjuvant radiochemotherapy may increase the risk in patients undergoing thoracoabdominal esophageal resections Dig Surg 18 3 2001 169 175 PubMed PMID: 11464005
24. C. Mariette, L. Dahan, F. Mornex, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901 J Clin Oncol 32 23 2014 Aug 10 2416 2422 PubMed PMID: 24982463